Daiichi Sankyo Announces ENLIVEN Phase 3 Study of Pexidartinib Met Primary Endpoint in Tenosynovial Giant Cell Tumor
Daiichi Sankyo Company, Limited announced that the pivotal phase 3 placebo-controlled ENLIVEN (NCT02371369) study of pexidartinib met its primary endpoint of tumor response as...
Boehringer Ingelheim expands collaboration with Sarah Cannon Research Institute to investigate novel immuno-oncology combination therapy
Boehringer Ingelheim and Sarah Cannon Research Institute announced an expansion of their strategic partnership to bring innovative treatments to cancer patients by developing novel...
Cerus And Kedrion Biopharma Enter Distribution Agreement For The Full INTERCEPT Blood System Portfolio In Italy
Cerus Corporation announced that it has entered into an agreement with Kedrion Biopharma to distribute the full complement of INTERCEPT Blood System products in...
Sancilio Pharma To Present An Update On Research In Sickle Cell At Upcoming National SCDAA Convention
Sancilio Pharmaceuticals Company, Inc. (SPCI) will present an update on the research program in the field of sickle cell disease, at the National Sickle...
BERG Enters Into An Agreement With Sanofi Pasteur To Identify Biomarkers Of Flu Vaccine Performance
BERG, a biopharmaceutical company that merges biology with technology announced a new research effort with Sanofi Pasteur, the influenza vaccine global leader. ...
Merrimack Receives Orphan Drug Designation For MM-121 For The Treatment Of Heregulin Positive Non-Small Cell Lung Cancer
Merrimack Pharmaceuticals, Inc. announced that the U.S. FDA has granted orphan drug designation to MM-121, its investigational drug candidate, for the treatment of heregulin...
Bayer leads the way in modern development standards for evidence-based phytomedicine with Iberogast
As consumer demand for herbal medicine continues to grow, the healthcare industry is under increasing pressure to demonstrate how plant-based products deliver the same...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...